Skip to main content
Clinical Trials/NCT00821275
NCT00821275
Unknown
Phase 2

Multi-Center Clinical Trial of Uterine Artery Embolization Treatment of Uterine Leiomyoma

Sun Yat-sen University4 sites in 1 country900 target enrollmentJanuary 2008
ConditionsLeiomyoma

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Leiomyoma
Sponsor
Sun Yat-sen University
Enrollment
900
Locations
4
Primary Endpoint
quality of life
Last Updated
17 years ago

Overview

Brief Summary

The efficacy and safety of uterine artery embolization, as compared with standard surgical methods, for the treatment of symptomatic uterine fibroids remain uncertain. The purpose of this trial is to evaluate the uterine volume and tumor size reduction, symptomatic relief, complication, fertility, ovarian function and quality of life with uterine artery embolization for uterine fibroids comparing with standard surgical methods.

Registry
clinicaltrials.gov
Start Date
January 2008
End Date
December 2018
Last Updated
17 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Sun Yat-sen University

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of symptomatic uterine leiomyoma

Exclusion Criteria

  • pregnancy
  • iodine agent allergy
  • patient refuse to take part in this trial
  • tumour size is less than 3cm or beyond 10cm
  • with endometriosis
  • with malignant diseases
  • with abnormal coagulation function which can't restore
  • with acute inflammatory diseases or acute episode of chronic inflammatory diseases
  • with severe heart, lung, liver and kidney, et al. organ diseases.

Outcomes

Primary Outcomes

quality of life

Time Frame: 1,3,5,10 year.

pregnant

Time Frame: 3 years

Secondary Outcomes

  • tumor recurrence(1,3,5,10 years)
  • complications(3,6,12,24 months)
  • ovarian functions(3,6,12 months, 2,3,5 and 10 years)
  • symptom relief(3,6,12,24 months)
  • tumour volume(3,6,12 18 24 months and 3,5,10 years)

Study Sites (4)

Loading locations...

Similar Trials